Risk of Pleural Recurrence in Early-Stage Non-small Cell Lung Cancer in Patients Treated With Surgery vs Stereotactic

Horiana Grosu1, Manuel Cabrera1, Daniella Lizarraga Madrigal2

  • 1Pulmonary Medicine, MD Anderson Cancer Center, Houston, USA.

Cureus
|December 13, 2024
PubMed
Summary

For non-small cell lung cancer (NSCLC) patients, surgery and radiotherapy showed no difference in ipsilateral pleural recurrence rates. This study compared treatment outcomes for early-stage NSCLC patients.